The study's findings come at a critical time for higher education, as institutions grapple with rising student attrition ...
Pfizer hosted a discussion with sell-side analysts to provide an update on one of the vaccine pipeline items – a second-generation Clostridioides difficile (C. diff) vaccine effort in Phase 2.